BOSTON SCIENTIFIC CORPORATION (BSX)

Every figure this model derived for BSX, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 904,000,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 539,000,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 7,972,000,000 AssetsCurrent 2026-06-30
current liabilities 6,428,000,000 LiabilitiesCurrent 2026-06-30
equity 24,930,000,000 StockholdersEquity 2026-06-30
interest expense 363,000,000 InterestExpense 2026-06-30
ocf 4,529,000,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 20,996,000,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 320,000,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up BSX on one particular measure came for.

RatioValue
cash operating margin28.03
current ratio1.3
current ratio reported1.24
deferred revenue growth2.29
dilution pct0.58
ebit cagr30.23
ebit yoy31.89
ev ebit19.2
ev owner earnings24.12
ev sales3.8
fcf margin17.27
growth cv0.34
interest cover11.44
net debt ebitda2.17
operating margin19.78
owner earnings margin15.74
revenue growth13.53
revenue growth per share12.87
roic8.86
rule of 4033.3
sbc pct revenue1.52

What to be careful about

What this model itself distrusts about BSX's figures. Written by the derivation as it ran, not added afterwards.